Current Problems in Cancer
Volume 30, Issue 6 , Pages 261-271 , November 2006

Is the Use of QOL Data Really Any Different than Other Medical Testing?

References 

  1. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. JAMA. 1995;273:59–64
  2. Ferrans CL, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37(4):336–342
  3. Patrick DL, Chiang YP. Convening health outcomes methodologists. Med Care. 2000;38(9 Suppl):II-3–II-6
  4. Ferrans CE. Development of a Quality of Life Index for patients with cancer. Oncol Nurs Forum. 1990;17(3 suppl):15–19
  5. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol. 1996;14:671–679
  6. Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced non-small cell lung carcinoma?. Cancer. 1999;85(2):333–340
  7. Montazeri A, Milory R, Hole D, McEwen J, Gillis C. Quality of life in lung cancer patients as an important prognostic factor. Lung Cancer. 2001;31:233–240
  8. Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schoffski P, et al. Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?. Eur J Cancer. 2006;42(1):42–49
  9. Morton RF, Sloan JA, Grothey A, Sargent DJ, McLeod H, Green EM, et al. A comparison of simple single-item toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. J Clin Oncol, ASCO Annual Meeting Proceedings. 2005;23(16S):750s
  10. Sloan JA, McLeod H, Sargent DJ, Zhao X, Fuchs CS, Ramanathan RK, et al. Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL). J Clin Oncol, ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2004;22(14S):3
  11. Sloan JA, Dueck A. Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat. 2004;14(1):73–96
  12. Fayers PM, Hopwood P, Harvey A, Girling D, Machin D, Stephens R. Quality of life assessment in clinical trials: guidelines and a checklist for protocol writers: the U.K (Medical Research Council Experience). Eur J Cancer. 1997;33(1):20–28
  13. Sloan JA, Symonds T, Vargas-Chanes D, Fridley B. Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Info J. 2003;37:23–31
  14. Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D’haese S, et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making?. J Clin Oncol. 2003;21(18):3502–3511
  15. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: the example of health-related quality of life: a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Info J. 2002;36:209–238
  16. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2006;February. Available from: http://www.fda.gov/cder/guidance/5460dft. Accessed February 27, 2006.
  17. Herrstedt J, Muss HB, Warr DG, Hesketh PJ, Eisenberg PD, Raftopoulos H, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer. 2005;104(7):1548–1555
  18. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–169
  19. Curran SL, Andrykowski MA, Studts JL. Short form of the profile of mood states (POMS-SF): psychometric information. Psychol Assess. 1995;7:80–83
  20. Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Suppl Care Cancer. 1999;7(5):332–335
  21. Detmar S, Mulller M, Schornagel J, Wever L, Aaronson N. Health-related quality-of-life assessments and patient-physician communication: a controlled randomized trial. JAMA. 2002;288(23):3024–3027
  22. Fayers P, Aaronson N, Bjordal K, Curran D, Groenvold M. EORTC QLQ-C30 Scoring Manual. (2nd ed). Brussels, Belgium: European Organization for Research on the Treatment of Cancer; 1999;
  23. Velikova G, Wright EP, Smith AB, Cull A, Gould A, Forman D, et al. Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol. 1999;17:998–1007
  24. Buxton J, White M, Osoba D. Patients’ experiences using a computerized program with a touch- sensitive video monitor for the assessment of health-related quality of life. Qual Life Res. 1998;7:513–519
  25. Cella D. Quality of life outcomes: measurement and validation. Oncology. 1996;10:233–246
  26. Rubin R. You may be pre-hypertensive. USA Today (May 14, 2003). Available at: http://www.usatoday.com/news/health/2003-05-14-us-guidelines-blood-pressure-x.htm. Accessed February 27, 2006.
  27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of Joint National Committee on Prevention, Detection, and Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572
  28. U. S. Department of Health and Human Services and the U.S. Department of Agriculture. Dietary Guidelines for Americans. 2005;Available from: http://www.health.gov/dietaryguidelines/dga2005/document/pdf/DGA2005.pdf. Accessed February 27, 2006.
  29. Parati G, Mancia G. Blood pressure variability as a risk factor. Blood Pressure Monitor. 2001;6(6):341–347
  30. Klee M, King M, Machin D, Hansen H. A clinical model for quality of life assessment in cancer patients receiving chemotherapy. Ann Oncol. 2000;11:23–30
  31. Hahn C, Dunn R, Halperin E. Routine screening for depression in radiation oncology patients. Am J Clin Oncol. 2004;27(5):497–499
  32. Levinson W, Roter D. Physician’s psychosocial beliefs correlate with their patient communication skills. J Gen Int Med. 1995;10(7):375–379
  33. Koller M, Heitmann K, Kussmann J, Lorenz W. Symptom reporting in cancer patients. II. Relations to social desirability, negative affect, and self-reported health behaviors. Cancer. 1999;86:1609–1620
  34. Grov EK, Dahl AA, Moum T, Fossa SD. Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Ann Oncol. 2005;16(7):1185–1191

PII: S0147-0272(06)00055-9

doi: 10.1016/j.currproblcancer.2006.08.004

Current Problems in Cancer
Volume 30, Issue 6 , Pages 261-271 , November 2006

Article Tools

* Image Usage & Resolution